E-Cigarette Maker Juul Mulls Potential Bankruptcy
Juul Labs Inc, backed by Altria Group Inc (NYSE: MO), has been exploring various options—including bankruptcy—after the FDA issued its marketing denial order.
Despite Solid Efficacy From Gene Therapy, This Analyst Cuts REGENXBIO’s Price Target
On Monday, REGENXBIO Inc (NASDAQ:RGNX) announced a program update from its ongoing clinical investigation of RGX-314 for wet AMD, a leading cause…
Sanofi In-Licenses Preclinical Genetic Disease Candidate From An Unknown Biotech
French pharma major Sanofi SA (NASDAQ:SNY) entered into a collaboration and licensing agreement with little-known U.S. biotech miRecule, an innovator of next-generation…
Vir Biotech Secures US Government Contract For Influenza & Other Infectious Disease Candidates
With its COVID-19 monoclonal antibody sidelined in the U.S. since April and plans for full approval no longer in the cards, Vir…
Why This Illumina Analyst Is Bullish About NovaSeq X+
Illumina, Inc.’s (NASDAQ: ILMN) NovaSeq X Plus is likely to become “the ultimate genome machine,” lending upside in 2024 and beyond, according to SVB Securities.
Summit Therapeutics Seeks Partnership For Phase 3 Infection Candidate Development
In an SEC filing, Summit Therapeutics Inc (NASDAQ: SMMT) said it would seek partners or divestiture of ridinilazole as the path forward for the clinical development of the asset.
Connect Biopharma Lead Candidate Aces Pivotal Atopic Dermatitis Trial In Chinese Patients
Connect Biopharma Holdings Limited (NASDAQ:CNTB) announced topline results for the primary analysis population of the pivotal trial of CBP-201, in patients…
FDA Puts Partial Hold On Aeglea’s Rare Disorder Trial In Pediatric Patients
Aeglea BioTherapeutics Inc (NASDAQ:AGLE) received an FDA letter responding to a recently submitted protocol amendment for the Phase 1/2 trial of…
Pfizer Touts Positive Data From Prostate Cancer Combo Therapy Trial
Pfizer Inc (NYSE:PFE) announced topline results from the Phase 3 TALAPRO-2 study of Talzenna (talazoparib) in combination with Xtandi (enzalutamide) in…